Bruderman Asset Management, LLC Amgen Inc Transaction History

Bruderman Asset Management, LLC

$55.7 Million
Q2 2022

A detailed history of Bruderman Asset Management, LLC transactions in Amgen Inc stock. As of the latest transaction made, Bruderman Asset Management, LLC holds 1,959 shares of AMGN stock, worth $576,984. This represents 0.86% of its overall portfolio holdings.

Number of Shares

1,959

Previous 1,951 0.41%

Holding current value

$576,984

Previous $474,000 0.63%

% of portfolio

0.86%

Previous 0.72%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$230.71 - $256.74 $1,845 - $2,053	8 Added 0.41%	1,959 $477,000
Q1 2022 May 13, 2022	SELL	$219.27 - $242.57 $108,977 - $120,557	-497 Reduced 20.3%	1,951 $474,000
Q4 2021 Feb 14, 2022	SELL	$198.88 - $227.6 $919,820 - $1.05 Million	-4,625 Reduced 65.39%	2,448 $550,000
Q3 2021 Oct 13, 2021	BUY	$212.27 - $248.7 $102,950 - $120,619	485 Added 7.36%	7,073 $1.5 Million
Q2 2021 Jul 14, 2021	BUY	$233.58 - $259.14 $35,504 - $39,389	152 Added 2.36%	6,588 $1.61 Million
Q1 2021 Apr 23, 2021	BUY	$221.91 - $258.6 $43,050 - $50,168	194 Added 3.11%	6,436 $1.6 Million
Q4 2020 Jan 29, 2021	BUY	$216.38 - $257.67 $415,882 - $495,241	1,922 Added 44.49%	6,242 $1.44 Million
Q3 2020 Oct 14, 2020	SELL	$234.65 - $260.95 $62,182 - $69,151	-265 Reduced 5.78%	4,320 $1.1 Million
Q2 2020 Aug 06, 2020	BUY	$197.81 - $242.74 $117,894 - $144,673	596 Added 14.94%	4,585 $1.17 Million
Q1 2020 Apr 28, 2020	BUY	$182.24 - $241.7 $92,395 - $122,541	507 Added 14.56%	3,989 $789,000
Q4 2019 Feb 13, 2020	SELL	$189.21 - $243.2 $255,055 - $327,833	-1,348 Reduced 27.91%	3,482 $836,000
Q3 2019 Nov 14, 2019	BUY	$174.11 - $208.62 $10,098 - $12,099	58 Added 1.22%	4,830 $1.07 Million
Q2 2019 Aug 12, 2019	SELL	$166.7 - $195.41 $244,048 - $286,080	-1,464 Reduced 23.48%	4,772 $879,000
Q1 2019 May 14, 2019	SELL	$180.87 - $203.88 $6,511 - $7,339	-36 Reduced 0.57%	6,236 $1.19 Million
Q4 2018 Feb 11, 2019	BUY	$178.4 - $208.25 $252,257 - $294,465	1,414 Added 29.11%	6,272 $1.22 Million
Q3 2018 Nov 09, 2018	SELL	$185.29 - $208.89 $19,084 - $21,515	-103 Reduced 2.08%	4,858 $1.01 Million
Q2 2018 Aug 15, 2018	SELL	$166.05 - $186.51 $2.05 Million - $2.3 Million	-12,333 Reduced 71.31%	4,961 $916,000
Q1 2018 May 10, 2018	BUY	$169.43 - $198.0 $296,333 - $346,302	1,749 Added 11.25%	17,294 $2.95 Million
Q4 2017 Feb 06, 2018	BUY	$168.79 - $188.59 $462,484 - $516,736	2,740 Added 21.4%	15,545 $2.7 Million
Q3 2017 Nov 13, 2017	BUY	$167.29 - $191.0 $2.14 Million - $2.45 Million	12,805	12,805 $2.39 Million

Others Institutions Holding AMGN

# of Institutions

3,122

Shares Held

410M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $158B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bruderman Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bruderman Asset Management, LLC with notifications on news.

Account

Bruderman Asset Management, LLC Amgen Inc Transaction History